Cancer Talk Live - Targeting the Proteasome in Multiple Myeloma

April 27, 2011 - PRLog -- Cancer Talk Live is an engaging live broadcast featuring noted disease experts discussing the latest information on the biological basis for proteasome inhibitors in multiple myeloma patients. With differing thoughts on treatment, the panel discussion reveals the complex issues revolving around treatment of these patients.  At the conclusion of the activity, viewers should be able to:
* Review the biologic role of the proteasome and implications of inhibition
* Outline the mechanisms of action of proteasome inhibitors
* Evaluate efficacy data of proteasome inhibitors in the treatment of relapsed or refractory multiple myeloma
* Compare and contrast adverse events associated with proteasome inhibitors in relapsed or refractory multiple myeloma
* Formulate an appropriate treatment approach when given relapsed or refractory multiple myeloma case scenarios

Viewers are invited to proceed to a post-activity assessment upon completion of viewing the broadcast. A CME/CE certificate is available after completing the assessment. To access the program, please go to http://www.cancertalklive.net/event_1_11.html

# # #

Educational Concepts Group, LLC (ECG) is a full-service, accredited hematology/oncology medical education company providing live programs, case learning, educational bureaus and enduring programs to physicians, pharmacists and nurses.